Clinical Trial Update: Intravenous Immunoglobulin for Acute Intracranial Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous immunoglobulin for acute intracerebral hemorrhage with hypertensive etiology; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Intracerebral Hemorrhage
• Intracerebral Hemorrhage

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Wei Wang | Conditions: Intracranial Hemorrhage, Hypertensive | Phase 2 | Status: UNKNOWN